Health & Biotech
Weed Week: There’s a wave of THC-related vaping illnesses sweeping the US
MGC Pharma hits key milestone as prescription growth accelerates for its medicinal cannabis drugs
Health: Cynata has finally scored that Fujifilm deal; shares climb 27pc
Meeting demand for the booming growth in Australia’s aged care sector will require some innovative solutions
Dr Boreham’s Crucible: Imagion gears up for human breast cancer trials, but market value falls way short of peers
Weed Week: Australia’s medicinal cannabis sector had its ‘hockey stick’ moment in 2019
Cannabis regulation in Australia could be about to become way less complex
Biotech: Mesoblast scores $US150m stem cell partnership to treat back pain, shares jump
How Opthea became a $1 billion stock in a month, and analysts reckon there’s still more to come
Dr Boreham’s Crucible: Antisense wants to conquer the less crowded DMD market
Pot: THC Global secures another 24 hectares ahead of 2020 product run
Check-up: Doggy cancer biotech PharmAust leads the pack
Health: Orthocell has done it again as patients regain shoulder function following CelGro surgery
This index of biotech stocks is up 782 per cent since the GFC
Ethics body approves another clinical trial using MGC Pharma’s epilepsy drug
Why more small caps are breaking into South American cannabis
Dr Boreham’s Crucible: What Anatara needs for its diarrhoea treatment to be more than just snake oil
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
